CN1026788C - 三唑类抗真菌剂的制备方法 - Google Patents

三唑类抗真菌剂的制备方法 Download PDF

Info

Publication number
CN1026788C
CN1026788C CN91100706A CN91100706A CN1026788C CN 1026788 C CN1026788 C CN 1026788C CN 91100706 A CN91100706 A CN 91100706A CN 91100706 A CN91100706 A CN 91100706A CN 1026788 C CN1026788 C CN 1026788C
Authority
CN
China
Prior art keywords
formula
compound
reaction
described method
triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN91100706A
Other languages
English (en)
Chinese (zh)
Other versions
CN1053787A (zh
Inventor
史蒂文·J·雷
肯尼思·理查德逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10670334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1026788(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1053787A publication Critical patent/CN1053787A/zh
Application granted granted Critical
Publication of CN1026788C publication Critical patent/CN1026788C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN91100706A 1990-02-02 1991-02-02 三唑类抗真菌剂的制备方法 Expired - Lifetime CN1026788C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909002375A GB9002375D0 (en) 1990-02-02 1990-02-02 Triazole antifungal agents
GB9002375.5 1990-02-02

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN94102354A Division CN1040504C (zh) 1990-02-02 1994-02-26 含三唑类的药用组合物的制备方法

Publications (2)

Publication Number Publication Date
CN1053787A CN1053787A (zh) 1991-08-14
CN1026788C true CN1026788C (zh) 1994-11-30

Family

ID=10670334

Family Applications (2)

Application Number Title Priority Date Filing Date
CN91100706A Expired - Lifetime CN1026788C (zh) 1990-02-02 1991-02-02 三唑类抗真菌剂的制备方法
CN94102354A Expired - Lifetime CN1040504C (zh) 1990-02-02 1994-02-26 含三唑类的药用组合物的制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN94102354A Expired - Lifetime CN1040504C (zh) 1990-02-02 1994-02-26 含三唑类的药用组合物的制备方法

Country Status (42)

Country Link
US (2) US5567817A (enExample)
EP (1) EP0440372B1 (enExample)
JP (2) JP2625584B2 (enExample)
KR (1) KR930011039B1 (enExample)
CN (2) CN1026788C (enExample)
AP (2) AP223A (enExample)
AT (1) ATE90090T1 (enExample)
AU (1) AU625188B2 (enExample)
BA (1) BA97298A (enExample)
BG (1) BG60032B2 (enExample)
BR (1) BR9100435A (enExample)
CA (2) CA2035314C (enExample)
CZ (1) CZ279339B6 (enExample)
DE (2) DE10299035I2 (enExample)
DK (1) DK0440372T3 (enExample)
EG (1) EG19750A (enExample)
ES (1) ES2055523T4 (enExample)
FI (3) FI971238L (enExample)
GB (1) GB9002375D0 (enExample)
HK (1) HK219396A (enExample)
HU (2) HU205351B (enExample)
IE (1) IE64774B1 (enExample)
IL (2) IL97045A (enExample)
IN (1) IN176148B (enExample)
IS (1) IS1629B (enExample)
LU (1) LU90960I2 (enExample)
LV (1) LV10615B (enExample)
MA (1) MA22054A1 (enExample)
MX (1) MX24363A (enExample)
MY (1) MY105494A (enExample)
NL (1) NL300100I2 (enExample)
NO (2) NO176796C (enExample)
NZ (1) NZ247205A (enExample)
OA (1) OA09480A (enExample)
PE (1) PE31691A1 (enExample)
PL (3) PL169332B1 (enExample)
PT (1) PT96617B (enExample)
RO (1) RO109648B1 (enExample)
RU (2) RU2036194C1 (enExample)
SK (1) SK278215B6 (enExample)
YU (1) YU48105B (enExample)
ZA (1) ZA91761B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1919846A (zh) * 2006-09-14 2007-02-28 北京博尔达生物技术开发有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
WO2020169025A1 (zh) 2019-02-19 2020-08-27 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
GB2281297A (en) * 1993-08-27 1995-03-01 Merck & Co Inc Quinazoline compounds
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
DE19500379A1 (de) * 1995-01-09 1996-07-11 Basf Ag Fluorierte Pyrimidine als Herbizide
GB9516121D0 (en) 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9605705D0 (en) * 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
ID16956A (id) * 1996-05-24 1997-11-27 Schering Corp Komposisi antijamur dengan ketersediaan hayati yang tertingkatkan
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
GB9713149D0 (en) * 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
CN1081189C (zh) * 1998-07-17 2002-03-20 国家医药管理局四川抗菌素工业研究所 唑醇类新衍生物及其制备方法和医药用途
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
WO2000076556A2 (en) * 1999-06-11 2000-12-21 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6319933B1 (en) 2000-04-17 2001-11-20 Basilea Pharmaceutica Ag Azole derivatives
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
EP1458416A1 (en) 2001-12-13 2004-09-22 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
CN100379733C (zh) * 2002-10-08 2008-04-09 南京康泽医药科技有限公司 三唑类抗真菌药物及其制备方法
US20040098839A1 (en) * 2002-11-27 2004-05-27 Pfizer Inc. Crystallization method and apparatus using an impinging plate assembly
WO2006065726A2 (en) * 2004-12-14 2006-06-22 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
JP5055263B2 (ja) 2005-03-30 2012-10-24 ダエウン ファーマシューティカル カンパニー リミテッド 抗真菌性トリアゾール誘導体
CA2640922A1 (en) * 2006-02-01 2007-11-22 Medichem, S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
JP2010510248A (ja) * 2006-11-21 2010-04-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分をターゲティング部分と組み合わせて使用する金属酸化還元酵素阻害剤
KR100889937B1 (ko) 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
GB2452049A (en) * 2007-08-21 2009-02-25 Alpharma Aps Process for the preparation of voriconazole
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
US20110224232A1 (en) * 2008-05-06 2011-09-15 Board Of Regents, The University Of Texas System Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation
JP2009286756A (ja) 2008-05-30 2009-12-10 Fujifilm Finechemicals Co Ltd トリアゾール誘導体またはその塩
RU2472510C2 (ru) * 2008-06-06 2013-01-20 Гленмарк Фармасьютикалс Лимитед Стабильная лекарственная форма для местного применения, содержащая вориконазол
WO2010095145A1 (en) * 2009-02-17 2010-08-26 Glenmark Generics Limited Process for the preparation of voriconazole
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
EA201270283A1 (ru) 2009-08-19 2012-12-28 Рациофарм Гмбх Способ получения соэвапоратов и комплексы, содержащие вориконазол и циклодекстрин
KR20150043548A (ko) 2009-10-01 2015-04-22 앱탈리스 파마테크, 인코포레이티드 경구 투여용 코르티코스테로이드 조성물
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
CN102753543A (zh) 2009-12-30 2012-10-24 麦迪凯姆股份公司 药用用途的1-(1h-1,2,4-三唑-1-基)-2-丁醇衍生物，以及使用具有基本上未定义晶形的1-(1h-1,2,4-三唑-1-基)-2-丁醇衍生物制备所述1-(1h-1,2,4-三唑-1-基) -2-丁醇衍生物
KR100971371B1 (ko) 2010-02-04 2010-07-20 동국제약 주식회사 신규한 중간체를 이용한 보리코나졸의 제조방법
EP2545039A1 (en) 2010-03-10 2013-01-16 Synthon BV A process for making voriconazole
EP2409699B1 (en) 2010-07-23 2014-04-30 Combino Pharm, S.L. Stable compositions of voriconazole
CN101914091B (zh) * 2010-07-25 2015-05-27 浙江华海药业股份有限公司 一种制备伏立康唑中间体的方法
WO2012114273A1 (en) 2011-02-21 2012-08-30 Ranbaxy Laboratories Limited An improved process for the preparation of voriconazole and intermediates thereof
PL2720723T3 (pl) 2011-06-15 2018-10-31 Synthon Bv Stabilizowana kompozycja worykonazolu
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
BR112014028069A2 (pt) 2012-05-11 2017-08-08 Cipla Ltd composição farmacêutica oftálmica, processo para a preparação de uma composição farmacêutica oftálmica, uso de uma composição farmacêutica oftálmica, e, método para a prevenção ou tratamento de uma infecção fúngica
US9388167B2 (en) 2012-10-15 2016-07-12 Pfizer Ireland Pharmaceuticals Process for the preparation of voriconazole and analogues thereof
BR112015018547A2 (pt) * 2013-02-04 2017-07-18 Syngenta Participations Ag microbiocidas
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
JP6262972B2 (ja) * 2013-09-17 2018-01-17 公益財団法人微生物化学研究会 化合物、及びその製造方法、並びにボリコナゾールの製造方法
CN107660203A (zh) 2015-04-02 2018-02-02 拜耳作物科学股份公司 作为杀真菌剂的三唑衍生物
CN104987325B (zh) * 2015-06-30 2017-03-29 扬子江药业集团南京海陵药业有限公司 一种伏立康唑的制备方法
CN106117186B (zh) * 2016-06-12 2018-08-24 重庆莱美隆宇药业有限公司 一种伏立康唑及其中间体的制备方法
CN107556294A (zh) * 2016-06-30 2018-01-09 陕西合成药业股份有限公司 一种新型抗真菌感染药物及其制备方法和用途
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP3581566A3 (en) * 2016-11-28 2020-01-22 Cellix Bio Private Limited Compositions and methods for the treatment of fungal infections
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
EP3584245A4 (en) * 2017-02-17 2020-08-26 Wuhan LL Science And Technology Development Co., Ltd. TRIAZOLE ANTIBACTERIAL DERIVATIVE, ASSOCIATED PHARMACEUTICAL COMPOSITION AND USE
US12691128B2 (en) 2019-10-01 2026-07-28 Ellodi Pharmaceuticals, L.P. Methods of treating eosinophilic esophagitis and reducing candidiasis
CN111440152B (zh) * 2020-05-18 2022-09-27 浙江诚意药业股份有限公司 一种伏立康唑的制备方法
WO2021245703A2 (en) 2020-06-06 2021-12-09 Inventia Healthcare Limited Stable liquid compositions of posaconazole
CN112079819B (zh) * 2020-09-24 2022-06-17 南京易亨制药有限公司 一种改进的伏立康唑消旋体制备方法
CN114907319B (zh) * 2021-02-06 2024-06-14 华创合成制药股份有限公司 一种氘代三唑类化合物及其制备方法和用途
CN117069693A (zh) * 2022-05-16 2023-11-17 上海济煜医药科技有限公司 一类含胺基结构化合物的制备方法及作为抗菌剂的应用
CN115724829A (zh) * 2022-12-23 2023-03-03 天津力生制药股份有限公司 一种分离真菌药物中间体杂质的液相色谱制备方法
CN116730985A (zh) * 2023-06-20 2023-09-12 天津力生制药股份有限公司 一锅法制备伏立康唑的合成方法
CN118307408B (zh) * 2024-04-10 2025-03-21 上海恩氟佳科技有限公司 2-氟丙酰乙酸乙酯的制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000138A (en) * 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
DE2431407C2 (de) * 1974-06-29 1982-12-02 Bayer Ag, 5090 Leverkusen 1,2,4-Triazol-1-yl-alkanone und -alkanole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
US4654332A (en) * 1979-03-07 1987-03-31 Imperial Chemical Industries Plc Heterocyclic compounds
US4551469A (en) * 1979-03-07 1985-11-05 Imperial Chemical Industries Plc Antifungal triazole ethanol derivatives
US4927839A (en) * 1979-03-07 1990-05-22 Imperial Chemical Industries Plc Method of preventing fungal attack on wood, hides, leather or paint films using a triazole
US4259505A (en) * 1980-03-04 1981-03-31 Ciba-Geigy Corporation Process for the preparation of 1H-azole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
US5395942A (en) * 1980-06-02 1995-03-07 Zeneca Limited Heterocyclic compounds
EP0131684B1 (en) * 1980-08-18 1992-03-11 Imperial Chemical Industries Plc Use of triazolylethanol derivatives and their compositions as non-agricultural fungicides
EP0158741A3 (en) * 1980-11-19 1986-02-12 Imperial Chemical Industries Plc Intermediates for fungicidal triazole and imidazole compounds
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
US5466821A (en) * 1981-03-18 1995-11-14 Zeneca Limited Heterocyclic compounds
US5204363A (en) * 1981-03-18 1993-04-20 Imperial Chemical Industries Plc Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
ES523184A0 (es) * 1982-06-17 1985-04-01 Pfizer Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
DE3228870A1 (de) * 1982-08-03 1984-02-09 Bayer Ag, 5090 Leverkusen Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
DE3242252A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
DE3245504A1 (de) * 1982-12-09 1984-06-14 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
GB8301699D0 (en) * 1983-01-21 1983-02-23 Pfizer Ltd Antifungal agents
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
JPS59142480U (ja) * 1983-03-15 1984-09-22 サンデン株式会社 スクロ−ル型流体装置
GR81556B (enExample) * 1983-05-09 1984-12-11 Stauffer Chemical Co
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
GB8424799D0 (en) * 1984-10-02 1984-11-07 Ici Plc Biocide composition
GB8506619D0 (en) * 1985-03-14 1985-04-17 Pfizer Ltd Triazole antifungal agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US4965281A (en) * 1986-06-23 1990-10-23 E. I. Du Pont De Nemours And Cmopany Antifungal carbinols
US5084465A (en) * 1986-06-23 1992-01-28 Du Pont Merck Pharmaceutical Company Antifungal carbinols
US4980367A (en) * 1987-12-17 1990-12-25 E. I. Du Pont De Nemours And Company Antifungal carbinols
DE3784787T2 (de) * 1986-06-23 1994-01-20 Du Pont Merck Pharma Fungizide Karbinole.
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
ES2059408T3 (es) * 1987-02-10 1994-11-16 Abbott Lab Un proceso para la preparacion de un compuesto.
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
GB8729083D0 (en) * 1987-12-12 1988-01-27 Pfizer Ltd Triazole antifungal agents
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE3806089A1 (de) * 1988-02-26 1989-09-07 Basf Ag Azolylmethyloxirane und diese enthaltende fungizide
NO171272C (no) * 1988-03-04 1993-02-17 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
DE3809069A1 (de) * 1988-03-18 1989-09-28 Basf Ag Azolylmethylallylalkohole und diese enthaltende fungizide
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터
US5132319A (en) * 1991-03-28 1992-07-21 Merck Frosst Canada, Inc. 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis
US5205354A (en) * 1992-01-28 1993-04-27 Lesage Philip G Vehicle radiator and method of making
EP0613890A1 (en) * 1993-02-28 1994-09-07 Nihon Nohyaku Co., Ltd. Novel triazole compound, process for preparing the same and antifungal agent containing the same
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
DE4408404A1 (de) * 1994-03-12 1995-09-14 Huels Chemische Werke Ag Verfahren zur Herstellung von Chlorpyrimidinen
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
ES2162019T3 (es) * 1995-01-30 2001-12-16 Syngenta Ltd Procedimiento para preparar 4,6-dicloro-pirimidina.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1919846A (zh) * 2006-09-14 2007-02-28 北京博尔达生物技术开发有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
CN1919846B (zh) * 2006-09-14 2013-01-02 大道隆达（北京）医药科技发展有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
WO2020169025A1 (zh) 2019-02-19 2020-08-27 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法

Also Published As

Publication number Publication date
HK219396A (en) 1997-01-03
IS3671A7 (is) 1991-08-03
FI971238A0 (fi) 1997-03-25
CA2285891A1 (en) 1991-08-03
NL300100I2 (nl) 2003-01-06
PL169307B1 (pl) 1996-06-28
FI20000084A7 (fi) 2000-01-17
FI971238A7 (fi) 1997-03-25
JP2848811B2 (ja) 1999-01-20
FI910508L (fi) 1991-08-03
EP0440372A1 (en) 1991-08-07
LV10615B (en) 1995-12-20
ES2055523T3 (es) 1994-08-16
MY105494A (en) 1994-10-31
SK278215B6 (en) 1996-04-03
CN1053787A (zh) 1991-08-14
IL97045A (en) 1995-11-27
AP9000237A0 (en) 1991-01-31
DE10299035I1 (de) 2003-05-22
BG60032B2 (bg) 1993-07-30
HU205351B (en) 1992-04-28
NO910368D0 (no) 1991-01-31
EG19750A (en) 1996-01-31
IL110322A0 (en) 1994-10-21
FI20000084L (fi) 2000-01-17
ES2055523T4 (es) 2011-04-11
LV10615A (lv) 1995-04-20
NO176796B (no) 1995-02-20
BR9100435A (pt) 1991-10-22
PL288901A1 (en) 1992-01-27
AU625188B2 (en) 1992-07-02
HU211582A9 (en) 1995-12-28
JPH04211078A (ja) 1992-08-03
IN176148B (enExample) 1996-02-10
HUT56361A (en) 1991-08-28
IL110322A (en) 1996-10-31
RU2114838C1 (ru) 1998-07-10
CA2285891C (en) 2004-01-06
DE10299035I2 (de) 2003-06-26
RU2036194C1 (ru) 1995-05-27
ZA91761B (en) 1992-09-30
EP0440372B1 (en) 1993-06-02
KR910021398A (ko) 1991-12-20
NZ247205A (en) 1993-09-27
BA97298A (bs) 2001-09-14
CA2035314C (en) 2000-01-18
NO2002006I2 (no) 2004-10-11
RO109648B1 (ro) 1995-04-28
DE69100095D1 (de) 1993-07-08
JPH09208583A (ja) 1997-08-12
YU17591A (sh) 1994-01-20
IE910342A1 (en) 1991-08-14
PT96617B (pt) 1998-07-31
DK0440372T3 (da) 1993-06-28
NO176796C (no) 1995-05-31
MX24363A (es) 1993-09-01
YU48105B (sh) 1997-03-07
CN1040504C (zh) 1998-11-04
US5773443A (en) 1998-06-30
NL300100I1 (nl) 2002-11-01
KR930011039B1 (ko) 1993-11-20
IE64774B1 (en) 1995-09-06
JP2625584B2 (ja) 1997-07-02
DE69100095T2 (de) 1993-09-09
AP223A (en) 1992-08-27
CN1100421A (zh) 1995-03-22
MA22054A1 (fr) 1991-10-01
ATE90090T1 (de) 1993-06-15
PL167294B1 (pl) 1995-08-31
PL169332B1 (pl) 1996-07-31
CA2035314A1 (en) 1991-08-03
NO910368L (no) 1991-08-05
IS1629B (is) 1996-07-19
FI971238L (fi) 1997-03-25
GB9002375D0 (en) 1990-04-04
US5567817A (en) 1996-10-22
AU7022391A (en) 1991-09-05
OA09480A (fr) 1992-11-15
CZ279339B6 (cs) 1995-04-12
PE31691A1 (es) 1991-11-29
LU90960I2 (fr) 2003-04-02
FI107608B (fi) 2001-09-14
CS9100249A2 (en) 1991-09-15
PT96617A (pt) 1991-10-15
FI910508A0 (fi) 1991-02-01
IL97045A0 (en) 1992-03-29

Similar Documents

Publication Publication Date Title
CN1053787A (zh) 三唑类抗真菌剂
CN1147471C (zh) 肾素抑制剂
CN1029231C (zh) 三唑类抗霉菌剂的制备方法
CN1061041C (zh) 哌啶类衍生物
CN1036456C (zh) 氨基取代的吡唑
CN1153765C (zh) 具有神经营养和保护活性的4-芳基-1-苯基烷基-1,2,3,6-四氢吡啶
CN1053190C (zh) 新的喹喔啉二酮衍生物、其制备方法和作为药物的应用
CN1032209C (zh) 抗局部缺血剂2-呱啶子基-1-链烷醇衍生物的制备方法
CN1193961A (zh) 取代的苄氨基哌啶化合物
CN1133837A (zh) 取代的1h-咪唑
CN1109054A (zh) 噁唑烷-2-酮衍生物
CN1910154A (zh) 用作分枝杆菌抑制剂的喹啉衍生物
CN1094726A (zh) 噻唑烷二酮衍生物，它们的制备方法和用途
CN1117965A (zh) 取代的4-苯基-吡啶酮和4-苯基-2-烷氧基吡啶
CN1085899A (zh) 7(2-氨乙基)-苯并噻唑酮
CN1800145A (zh) 取代的2－二烷基氨基烷基联苯衍生物
CN1062349A (zh) 用作药物的3-取代的呱啶类
CN1091636A (zh) 药物
CN1246110A (zh) 芳基哌啶子基丙醇和芳基哌嗪子基丙醇衍生物和含有它们的药物
CN1054980A (zh) 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物，它们的制备方法以及它们的中间体
CN1024663C (zh) 治疗气喘用的取代的四氢化萘类化合物的制备方法
CN1028997C (zh) 新蒽环型药物衍生物或其药学上允许的酸加成盐的制法
CN1044652A (zh) 吡咯烷化合物和其药物用途
CN1077457A (zh) 新化合物
CN1023485C (zh) 新的取代的甲硅烷亚烷基胺的制备方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20110202

Granted publication date: 19941130